Evaluating the economics of complementary and integrative medicine

Global Advances In Health and Medicine

Volumn 2, Issue 2, 2013, Pages 68-75

  Herman, Patricia M ^a,b  

^a RAND CORPORATION   (United States)

^b SAMUELI INSTITUTE   (United States)

Author keywords

Complementary and integrative medicine; Costs; Economic evaluation; Healthcare

Indexed keywords

ACUPUNCTURE; ALTERNATIVE MEDICINE; BACKACHE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST CONSEQUENCE ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; DECISION MAKING; ECONOMIC EVALUATION; EMPOWERMENT; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; INTEGRATIVE MEDICINE; LIFESTYLE MODIFICATION; NON INVASIVE PROCEDURE; OSTEOPATHIC MEDICINE; PATIENT ATTITUDE; PATIENT CARE; PATIENT SAFETY; PRODUCTIVITY; PUBLICATION; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; REVIEW; UNITED STATES; WELLBEING; WORK DISABILITY;

EID: 84977586459     PISSN: 2164957X     EISSN: 21649561     Source Type: Journal    
DOI: 10.7453/gahmj.2013.002     Document Type: Review

References (42)

1. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Hyattsville, MD: National Center for Health Statistics;2009.
2. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Hyattsville, MA: National Center for Health Statistics;2004.
3. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA. 1998;280(18):1569-75.
4. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. New Engl J Med. 1993;328:246-52.
5. Spinks J, Hollingsworth B. Are the economics of complementary and alternative medicine different to conventional medicine? Expert Rev Pharmacoecon Outcomes Res. 2009;9(1):1-4.
6. Drummond M, Manca A, Sculpher M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care. 2005;21(2):165-71.
7. Drummond M, M. B, Cook J, et al. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health. 2009;12(4):409-18.
8. Bonsel GJ, Rutten FFH, Uyl-de Groot CA. Economic evaluation alongside cancer trials: methodological and practical aspects. Eur J Cancer. 1993;29A(Suppl 7):S10-S14.
9. Williams NH, Edwards RT, Linck P, et al. Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial. Fam Pract. 2004;21(6):643-50.
10. Gold MR, Patrick DL, Torrance GW, et al. Identifying and valuing outcomes. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996:82-134.
11. van den Berg I, Kaandorp GC, Bosch JL, Duvekot JJ, Arends LR, Hunink MG. Cost-effectiveness of breech version by acupuncture-type interventions on BL 67, including moxibustion, for women with a breech foetus at 33 weeks gestation: a modelling approach. Complement Ther Med. 2010;18(2):67-77.
12. Hollinghurst S, Shaw A, Thompson EA. Capturing the value of complementary and alternative medicine: including patient preferences in economic evaluation. Complement Ther Med. 2008;16:47-51.
13. Wilson CJ, Datta SK. Tai chi for the prevention of fractures in a nursing home population: an economic analysis. J Clin Outcomes Manage. 2001;8(3):19-27.
14. Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW, Smith MD, editors. Health care cost, quality, and outcomes: ISPOR Book of Terms. Lawrencevill, NJ: International Society for Pharmacoeconomics and Outcomes Research; 2003.
15. Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
16. Drummond M, O'Brien B, Economics Workgroup. Economic analysis alongside clinical trials: practical considerations. J Rheumatol. 1995;22(7):1418-9.
17. Reinhold T, Witt CM, Jena S, Brinkhaus B, Willich SN. Quality of life and costeffectiveness of acupuncture treatment in patients with osteoarthritis pain. Eur J Health Econ. 2008;9(3):209-19.
18. Witt CM, Jena S, Selim D, et al. Pragmatic randomized trial evaluating the clinical and economic effectiveness of acupuncture for chronic low back pain. Am J Epidemiol. 2006;164(5):487-96.
19. Witt CM, Reinhold T, Brinkhaus B, Roll S, Jena S, Willich SN. Acupuncture in patients with dysmenorrhea: a randomized study on clinical effectiveness and cost-effectiveness in usual care. Am J Obstet Gynecol. 2008;198(2):166.e1-8.
20. Witt CM, Reinhold T, Jena S, Brinkhaus B, Willich SN. Cost-effectiveness of acupuncture treatment in patients with headache. Cephalalgia. 2008;28(4):334-45.
21. Witt CM, Reinhold T, Jena S, Brinkhaus B, Willich SN. Cost-effectiveness of acupuncture in women and men with allergic rhinitis: a randomized controlled study in usual care. Am J Epidemiol. 2009;169(5):562-571.
22. Zarnke KB, Levine MAH, O'Brien BJ. Cost-benefit analyses in the health-care literature: don't judge a study by its label. J Clin Epidemiol. 1997;50(7):813-822.
23. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. Third ed. Oxford: Oxford University Press; 2005.
24. Herman PM, Szczurko O, Cooley K, Mills EJ. Cost-effectiveness of naturopathic care for chronic low back pain. Altern Ther Health Med. Mar-Apr 2008;14(2):32-9.
25. Brown AP, Kennedy AD, Torgerson DJ, Campbell J, Webb JA, Grant AM. The OMENS trial: opportunistic evaluation of musculo-skeletal physician care among orthopaedic outpatients unlikely to require surgery. Health Bull. 2001;59(3):199-210.
26. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Second ed. Oxford: Oxford University Press; 1997.
27. Trichard M, Lamure E, Chaufferin G. Study of the practice of homeopathic general practitioners in France. Homeopathy. 2003;92:135-9.
28. Busato A, Eichenberger R, Kunzi B. Extent and structure of health insurance expenditures for complementary and alternative medicine in Swiss primary care. BMC Health Serv Res. Oct 11 2006;6:132.
29. Siegel JE, Weinstein MC, Torrance GW. Reporting cost-effectiveness studies and results. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Costeffectiveness in health and medicine. New York: Oxford University Press; 1996.
30. Gerkens S, Crott R, Cleemput I, et al. Comparison of three instruments assessing the quality of economic evaluations: a practical exercise on economic evaluations of the surgical treatment of obesity. Int J Technol Assess Health Care. 2008;24(3):318-325.
31. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996;276(16):1339-1341.
32. Ofman JJ, Sullivan SD, Neumann PJ, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Managed Care Pharm. 2003;9(1):53-61.
33. Ramsey SD, Sullivan SD. Weighing the economic evidence: guidelines for critical assessment of cost-effectiveness analyses. J Am Board Fam Pract. 1999;12(6):477-85.
34. Drummond MF, Jefferson TO; BMJ Economic Evaluation Working Party. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. August 3 1996;313:275-83.
35. Wonderling D, Vickers AJ, Grieve R, McCarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. BMJ. 2004;328(7442):747.
36. Hollinghurst S, Sharp D, Ballard K, et al. Randomised controlled trial of Alexander technique lessons, exercise, and massage (ATEAM) for chronic and recurrent back pain: economic evaluation. BMJ. 2008;337:a2656.
37. Donaldson C, Currie G, Mitton C. Cost effectiveness analysis in health care: contraindications. BMJ. 2002;325(7369):891-4.
38. Ellwein LB, Drummond MF. Economic analysis alongside clinical trials: bias in the assessment of economic outcomes. Int J Technol Assess Health Care. 1996;12(4):691-7.
39. Ratcliffe J, Thomas KJ, MacPherson H, Brazier J. A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis. BMJ. 15 Sep 2006;333(7569):626.
40. Sculpher MJ, Pang FS, Manca A, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004;8(49).
41. Drummond MF, Davies L. Economic analysis alongside clinical trials: revisiting the methodological issues. Int J Technol Assess Health Care. 1991;7(4):561-73.
42. National Center for Complementary and Alternative Medicine. What is complementary and alternative medicine (CAM)? [Website]. 2011; http://nccam.nih.gov/health/whatiscam/. Accessed October 29, 2011.